Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study
Clicks: 167
ID: 120853
2016
Abstract. Background. Botswana introduced monovalent G1P[8] rotavirus vaccine (RV1) in July 2012, providing one of the first opportunities to assess the effect
| Reference Key |
a.2016clinicaleffectiveness
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gastañaduy, Paul A.;Steenhoff, Andrew P.;Mokomane, Margaret;Esona, Mathew D.;Bowen, Michael D.;Jibril, Haruna;Pernica, Jeffrey M.;Mazhani, Loeto;Smieja, Marek;Tate, Jacqueline E.;Parashar, Umesh D.;Goldfarb, David M.; |
| Journal | clinical infectious diseases |
| Year | 2016 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.